back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-18 00:42 Tx date 2025-03-14 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$445,500
+825,000 vol $0.54 each |
2,675,000 | |
| Filed 2024-06-23 21:43 Tx date 2024-06-18 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-360,000
-450,000 vol $0.80 each |
1,850,000 | |
| Filed 2023-10-04 22:04 Tx date 2023-10-03 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,300,000 | |
| Filed 2023-05-09 19:22 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+52,080 vol |
52,080 | |
| Filed 2023-05-09 19:20 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,020
+52,080 vol $0.25 each |
114,760 | |
| Filed 2023-05-09 19:20 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-10,600 vol |
0 | |
| Filed 2023-05-09 19:19 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-52,080 vol |
10,600 | |
| Filed 2023-04-17 21:59 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+62,680 vol |
62,680 | |
| Filed 2023-04-17 21:59 Tx date 2015-10-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-14 13:29 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+20,001 vol |
26,668 | |
| Filed 2023-03-14 13:28 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+15,000 vol |
62,000 | |
| Filed 2023-03-14 13:27 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+19,500 vol |
47,000 | |
| Filed 2023-03-14 13:26 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+6,000 vol |
27,500 | |
| Filed 2023-03-14 13:25 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+6,000 vol |
21,500 | |
| Filed 2023-03-14 13:24 Tx date 2023-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
55 - Expiration of warrants
|
-500 vol |
15,500 | |
| Filed 2023-03-14 13:24 Tx date 2022-05-18 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
55 - Expiration of warrants
|
-500 vol |
11,000 | |
| Filed 2023-03-14 13:23 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+47,010 vol |
62,680 | |
| Filed 2023-01-16 17:04 Tx date 2023-01-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,333 vol |
15,670 | |
| Filed 2023-01-16 17:03 Tx date 2023-01-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-3,333 vol |
6,667 | |
| Filed 2022-09-05 19:08 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+10,000 vol |
10,000 |